Not Applicable
Generic Name: not applicable
Brand Names:
Dv Hp
INDICATIONS: For temporary relief of symptoms due to dizziness and light-headedness.
Overview
INDICATIONS: For temporary relief of symptoms due to dizziness and light-headedness.
Uses
INDICATIONS: For temporary relief of symptoms due to dizziness and light-headedness.
Dosage
DIRECTIONS: 10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS: If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in cool, dry place.
Frequently Asked Questions
What is Not Applicable used for?▼
INDICATIONS: For temporary relief of symptoms due to dizziness and light-headedness.
What are the important warnings for Not Applicable?▼
WARNINGS: If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in cool, dry place.
Related Medications
Gripe Water
gripe water
For infant relief of irritiability, hiccups, gas releif, digestive aid, bloating and colic.
Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride And Sodium Bicarbonate
polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate
Osmotic Laxative [EPC]
11 DESCRIPTION For oral solution: Each 4 liter (4L) GaviLyte-N jug contains a white powder for reconstitution. GaviLyte-N is a combination of polyethylene glycol 3350, an osmotic laxative, and electrolytes (sodium chloride, sodium bicarbonate and potassium chloride) for oral solution. Each 4 liter jug contains: polyethylene glycol 3350 420g, sodium bicarbonate 5.72 g, sodium chloride 11.2 g, potassium chloride 1.4 g.
Octreotide
octreotide
Somatostatin Analog [EPC]
11 DESCRIPTION MYCAPSSA delayed release capsules contain octreotide acetate, a somatostatin analog. Octreotide is known chemically as L-cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxy-methyl) propyl]-, cyclic (2→7)-disulfide; [R-(R*,R*)].
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.